2C-T-13
 | |
 | |
| Names | |
|---|---|
| Preferred IUPAC name 2-{2,5-Dimethoxy-4-[(2-methoxyethyl)sulfanyl]phenyl}ethan-1-amine | |
| Identifiers | |
CAS Number |
|
3D model (JSmol) |
|
| ChEMBL |
|
| ChemSpider |
|
PubChem CID |
|
| UNII |
|
CompTox Dashboard (EPA) |
|
InChI
| |
| |
| Properties | |
Chemical formula | C13H21NO3S |
| Molar mass | 271.38 g·mol−1 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).  N verify (what is  Y N ?) Infobox references | |
Chemical compound
2C-T-13 (2,5-dimethoxy-4-(β-methoxyethylthio)phenethylamine) is a psychedelic phenethylamine of the 2C family. It was presumably first synthesized by Alexander Shulgin and reported in his book PiHKAL.[1]
Chemistry
The drug has structural properties similar to mescaline and other drugs in the 2C-T series, with the most closely related compounds being 2C-T-7 and 2C-T-21.
General information
The dosage range of 2C-T-13 is typically 25 - 40 mg and its duration is approximately 6–8 hours according to Shulgin.[1] 2C-T-13 produces many closed-eye visuals and geometric patterns. It also produces slight visual distortion.[1]
Pharmacology
The mechanism that produces 2C-T-13's hallucinogenic and entheogenic effects has not been specifically established; however, it is most likely to result from action as a 5-HT2A serotonin receptor agonist in the brain, a mechanism of action shared by all of the hallucinogenic tryptamines and phenethylamines for which the mechanism of action is known.
Dangers
The toxicity of 2C-T-13 is not well documented. 2C-T-13 is slightly less potent than 2C-T-7, but it may be expected that at higher doses it would display similar toxicity to that of other phenethylamines of the 2C-T family.
Legality
2C-T-13 is not scheduled in the United States, but possession and sales of 2C-T-13 could be prosecuted under the Federal Analog Act because of its structural similarities to 2C-T-7.
As of October 31, 2016, 2C-T-13 is a controlled substance (Schedule III) in Canada.[2]
References
- ^ a b c PiHKAL #46 2C-T-13
- ^ "Regulations Amending the Food and Drug Regulations (Part J — 2C-phenethylamines)". 4 May 2016.
- v
- t
- e
2C family of psychedelics
- 2C-B
- 2C-B-AN
- 2C-Bn
- 2C-Bu
- 2C-C
- 2C-CN
- 2C-CP
- 2C-D
- 2C-E
- 2C-EF
- 2C-F
- 2C-G
- 2C-G-1
- 2C-G-2
- 2C-G-3
- 2C-G-4
- 2C-G-5
- 2C-G-6
- 2C-G-N
- 2C-H
- 2C-I
- 2C-iP
- 2C-N
- 2C-NH2
- 2C-O
- 2C-O-4
- 2C-P
- 2C-Ph
- 2C-SE
- 2C-T
- 2C-T-2
- 2C-T-3
- 2C-T-4
- 2C-T-5
- 2C-T-6
- 2C-T-7
- 2C-T-8
- 2C-T-9
- 2C-T-10
- 2C-T-11
- 2C-T-12
- 2C-T-13
- 2C-T-14
- 2C-T-15
- 2C-T-16
- 2C-T-17
- 2C-T-18
- 2C-T-19
- 2C-T-20
- 2C-T-21
- 2C-T-22
- 2C-T-22.5
- 2C-T-23
- 2C-T-24
- 2C-T-25
- 2C-T-27
- 2C-T-28
- 2C-T-30
- 2C-T-31
- 2C-T-32
- 2C-T-33
- 2C-TFE
- 2C-TFM
- 2C-YN
- 2C-V
